The COVID-19 vaccine developed by Oxford University and AstraZeneca is safe and produces an immune response in all adults, according to preparatory outcomes from a phase two trial.
The results declared in the Lancet medical journal on Thursday confirmed that the vaccine applicant was tested on 560 healthy adults and provoked a similar immune response among those aged between 18 and 55 and those over 56-years-old.
“We hope that this means our vaccine will help to protect some of the most vulnerable people in society, but further research will be needed before we can be sure,” Dr. Maheshi Ramasamy, a co-author of the study at the University of Oxford, said.
The General Union of University Hospital Doctors, Pharmacists, and Dentists in Tunisia announced a collective…
A heated controversy is shaking France after the publication of a racist tweet targeting a…
The President of the Tunisian Organisation of Young Doctors, Wajih Dhokkar, confirmed the success of…
United Nations Secretary-General Antonio Guterres joined the world in mourning the death of Pope Francis on Monday,…
On Monday, April 21, 2025, former magistrate and lawyer Ahmed Souab was arrested by police…
Who would have expected that Argentina, with its staggering and abyssal debt to the IMF,…
This website uses cookies.